ACE2 receptor active site, we performed an extensive evaluation with the MD simulation, inspecting the main interactions formed by Butein throughout the binding cavity. The results of the evaluation regarding the hMOMIPP penetrates the blood-Mind barrier and inhibits progress of intracerebral U251 xenografts. a MOMIPP (80?mg/kg) was administered by